Back to company

PHARMCO II ApS: Financial statements 2017

CVR: 25202899

PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -18,126 and a net result of DKK 2,785,070 compared with DKK 2,271,044 the year before. Equity amounted to DKK 59,493,125. The solvency ratio was 98.7%.

Gross Profit
-18,126 kr.
Profit/Loss
2,785,070 kr.
Equity
59,493,125 kr.
Total Assets
60,247,237 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--18 t.2.8 mio.59.5 mio.-
2016--21 t.2.3 mio.56.7 mio.-
2015-17.8 mio.3 mio.-37
2014--21 t.1.8 mio.52.8 mio.34
2013--19 t.3.6 mio.51.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMCO II ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

PHARMCO II ApS: The 2016 annual report is outJun 2, 2017

PHARMCO II ApS has published its annual report for 2016. Gross profit came to DKK -20,625, and the net result was DKK 2,271,044.

About PHARMCO II ApS

PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity amounted to DKK 107,079,000.